USPTO trademark

ASCENDIS SIGNATURE ACCESS PROGRAM

RegisteredUSPTOWord markClass 35Class 36Class 38Class 41+1

"ASCENDIS SIGNATURE ACCESS PROGRAM" is a word mark owned by Ascendis Pharma A/S, filed at the USPTO on November 30, 2020. It is registered and covers classes 35, 36, 38, 41 and 44.

Official USPTO record
ASCENDIS SIGNATURE ACCESS PROGRAM trademark as filed
As filed with the USPTO
Status
Registered
Since November 30, 2021
Filed
November 30, 2020
Registered
November 30, 2021
Priority date
November 20, 2020
Claimed from Denmark
Application no.
90347895
Registration no.
6573128
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns ASCENDIS SIGNATURE ACCESS PROGRAM

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services ASCENDIS SIGNATURE ACCESS PROGRAM is filed for, grouped by Nice class.

  • Providing consumer product information relating to pharmaceutical products and medical devices; medical cost management; business administrative services for medical referrals; maintaining a registry of certified medical professionals; advertising services to promote public awareness of medical conditions; medical claims management services for patients, namely, receiving and processing transactions that are originated by physicians, hospitals, and ancillary medical care providers; administering discount programs in relation to pharmaceutical products and medical devices, namely, enabling participant members to obtain discounts on the purchase of pharmaceutical products and medical devices; Administering pharmacy reimbursement programs, namely, business administration of pharmacy reimbursement programs; business administration of pharmacy reimbursement programs, namely, assisting customers in obtaining reimbursement under pharmacy reimbursement programs; retail store services and online retail store services featuring pharmaceuticals and medical devices; retail store services and online retail store services featuring pharmaceuticals, namely, advancement of drugs to patients to initiate therapy while benefit or insurance claims are pending; business administration of pharmacy services, namely, administering a quick start program providing patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage

  • Providing information in insurance matters; insurance services, namely, assisting patients in preparing claims and obtaining repayment of medical expenses; insurance administration of prescription drug benefit plans; advancement of funds for covering pharmaceutical and medical expenses; Administering pharmacy reimbursement programs, namely, financial administration of pharmacy reimbursement programs; financial administration of pharmacy reimbursement programs, namely, assisting customers in obtaining reimbursement under pharmacy reimbursement programs; pharmacy benefit management services, namely, administering a quick start program providing patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage; pharmaceutical and pharmacy benefit management services, namely, provision of information for patients in relation to obtaining benefits relating to medical treatment and pharmaceuticals; pharmaceutical and pharmacy benefit management services, namely, assisting patients in preparing claims and obtaining benefits; providing information about patient reimbursement programs for patients and insurance coverage for pharmaceuticals and medical devices

  • Provision of platforms, portals and websites on the Internet for electronic transmission of medical data between patients and their healthcare providers

  • Educational and teaching services, namely, providing conferences, symposiums, seminars, workshops, lectures, classes and online education seminars in the field of pharmaceuticals, medicine, health care, and pharmacy reimbursement programs; Arranging and conducting of conferences, symposiums, seminars, workshops, lectures and online education seminars, and distribution of educational materials in connection therewith, in the fields of pharmaceutical, medical and healthcare; Editorial reporting services; news syndication reporting; Non-downloadable electronic publications in the nature of ad boards, magazines, journals and articles in the field of pharmaceutical, medical and healthcare

  • Medical and healthcare services; Medical testing for diagnostic or treatment purposes; Consultancy relating to medical testing, medicines, health and pharmaceutical products; Providing and sharing of information and advice relating to medical testing, medicine, health and pharmaceutical preparations

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Registered-principal register
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Law office publication review completed
  6. Approved for pub - principal register
  7. Examiner's amendment entered
  8. Notification of examiners amendment e-mailed
  9. Examiners amendment e-mailed
  10. Examiners amendment -written

10 earlier steps on the official record.

FAQ

About ASCENDIS SIGNATURE ACCESS PROGRAM

Who owns the trademark "ASCENDIS SIGNATURE ACCESS PROGRAM"?

The USPTO trademark "ASCENDIS SIGNATURE ACCESS PROGRAM" (application 90347895) is owned by Ascendis Pharma A/S.

What is the status of "ASCENDIS SIGNATURE ACCESS PROGRAM"?

Its status at the USPTO is: registered.

When was "ASCENDIS SIGNATURE ACCESS PROGRAM" registered?

It was registered on November 30, 2021.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ASCENDIS SIGNATURE ACCESS PROGRAM and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2ca4-fe7d-76ac-a0ce-1492d175d208
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ca4-fe7d-76ac-a0ce-1492d175d208",
  "object": "trademark",
  "mark_text": "ASCENDIS SIGNATURE ACCESS PROGRAM",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90347895",
  "filing_date": "2020-11-30",
  "nice_classes": [
    35,
    36,
    38,
    41,
    44
  ],
  "owners": [
    {
      "name": "Ascendis Pharma A/S",
      "entity_id": "ent_019eb711-cfef-70e8-9cf4-4a4fa9a981de"
    }
  ]
}